Today (August 14), the 6th In-depth CNS Drug Focus Forum (ICNS 2026) concluded successfully in Nanjing. Wayshine Biopharm was honored to be invited to this major industry event. Dr. Zhong Wei, Founder of Wayshine Biopharm, was featured as a keynote speaker at the "Development Strategies and R&D Progress" session, delivering an outstanding presentation titled WSD0628 Radiotherapy Sensitizers Capable of Penetrating the Blood-Brain Barrier.

（Source：https://mp.weixin.qq.com/s/HJqMNDMwELwoqH4p0XWL3g）